Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
498 hedge funds and large institutions have $11.9B invested in Abiomed Inc in 2020 Q3 according to their latest regulatory filings, with 81 funds opening new positions, 164 increasing their positions, 168 reducing their positions, and 42 closing their positions.
93% more first-time investments, than exits
New positions opened: 81 | Existing positions closed: 42
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
13% more capital invested
Capital invested by funds: $10.5B → $11.9B (+$1.37B)
8% more funds holding
Funds holding: 460 → 498 (+38)
2% less repeat investments, than reductions
Existing positions increased: 164 | Existing positions reduced: 168
11% less call options, than puts
Call options by funds: $191M | Put options by funds: $213M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAMU
AEGON Asset Management (UK)
Edinburgh,
United Kingdom
|
+$29.3M |
| 2 |
Two Sigma Investments
New York
|
+$29.1M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$28.9M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$20.5M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$19.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Primecap Management
Pasadena,
California
|
-$121M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$118M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$42.7M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$36.4M |
| 5 |
PGEBT
Pactiv General Employee Benefit Trust
Lake Forest,
Illinois
|
-$26M |
ABMD Hedge Fund Activity: Q3 2020 in Review
498 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q3 2020, worth a combined $11.9B — up 13% from $10.5B a quarter earlier.
Buyers outnumbered sellers: 81 funds opened new ABMD positions and 42 closed out — a net gain of 39 holders — while 164 added to existing stakes and 168 trimmed.
The largest buyer was AEGON Asset Management (UK), opening a new position worth an estimated $29.3M. The largest seller was Primecap Management, cutting an estimated $121M.
- 498 institutional investors held Abiomed Inc (ABMD) as of Q3 2020, up from 460 in Q2 2020.
- Funds reported $11.9B of Abiomed Inc stock for Q3 2020, up 13% quarter-over-quarter.
- 81 funds opened new Abiomed Inc positions in Q3 2020 and 42 closed out, a net change of +39 holders.
- The largest Abiomed Inc buyer in Q3 2020 was AEGON Asset Management (UK), an estimated $29.3M added.
- The largest Abiomed Inc seller in Q3 2020 was Primecap Management, an estimated $121M sold.
Based on aggregated 13F filings for Q3 2020.